Deep inside Alphabet, the parent company of Google, a secretive lab is working on a promise so audacious it sounds like science fiction: to “solve all diseases.” The company, Isomorphic Labs, is now preparing to start its first human clinical trials for cancer drugs designed entirely by artificial intelligence.
In a recent interview with Fortune, Colin Murdoch, President of Isomorphic Labs and Chief Business Officer of Google DeepMind, confirmed the company is on the verge of this monumental step. For anyone who has watched a loved one battle a devastating illness, the hope this offers is immense. But for a public increasingly wary of AI’s power, it raises a chilling question: can we really trust a “black box” algorithm with our lives?
They can even solve basic arithmetic and they are going to cure all deseases, right…
Different models, different problems. While LLMs are a bit of a parlor trick, this particular application is actually well suited for AI, as it involves the search for patterns in massive amounts of data. It’s not just guessing the next word, but actually seeking probabilistic causes and effects hidden within more data than researchers could possibly search on their own.
You’re misunderstanding what’s happening here. You’re talking about an LLM. That’s not what this is
I know it is not an LLM, I’m just saying it in not solving diseases, its finding most likely protein shapes. It was more of a rant against AI hype and how they present it. Perhaps I should have worded that better.